نتائج البحث - "Second Primary"

1

Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice

المؤلفون: Hanae Ida, Takafumi Koyama, Takaaki Mizuno, Kuniko Sunami, Takashi Kubo, Kazuki Sudo, Kayoko Tao, Makoto Hirata, Kan Yonemori, Ken Kato, Takuji Okusaka, Yuichiro Ohe, Yoshiyuki Matsui, Naoya Yamazaki, Chitose Ogawa, Akira Kawai, Yoshitaka Narita, Minoru Esaki, Noboru Yamamoto

المصدر: Cancer Science. 113:4300-4310

مصطلحات موضوعية: Adult, Aged, 80 and over, Cancer Research, Adolescent, Neoplasms, Second Primary, Genomics, General Medicine, Middle Aged, Young Adult, Oncology, Child, Preschool, Neoplasms, Biomarkers, Tumor, Humans, Child, Aged

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ddd4175d169ea9cb6b1821d65644cd1Test
https://doi.org/10.1111/cas.15586Test

2

دورية أكاديمية

Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort

المؤلفون: DCOG-LATER Study Group

المساهمون: PMC Medisch specialisten, Speerpunt, Zorg en O&O, Child Health, SCT patientenzorg, Klinische Fysica RT, Onderzoeksgroep 7, Brain, ZL Cerebrovasculaire Ziekten Medisch

وصف الملف: image/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/392061Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/392061Test

View record in BASE

3

Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population‐based cohort

المؤلفون: Stephanie M. Wong, Lissa Ajjamada, Anna C. Weiss, Ipshita Prakash, Sonia Skamene, Jean Francois Boileau, Michael N. Pollak, Mark Basik

المصدر: Cancer. 128:1365-1372

مصطلحات موضوعية: Adult, Cohort Studies, Young Adult, Cancer Research, Carcinoma, Intraductal, Noninfiltrating, Oncology, Humans, Breast Neoplasms, Female, Neoplasms, Second Primary, Survivors, Child, Hodgkin Disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212bcb980573e1b077e75b9b017e4e78Test
https://doi.org/10.1002/cncr.34065Test

4

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment

المؤلفون: Marc Tischkowitz, Matthew J. Murray, Adam Shlien, Thomas R. W. Oliver, G. A. Amos Burke, Anna L. Godfrey, Michael Gattens, Wanhua Lu, Jyoti Nangalia, Jannat Ijaz, Tim H. H. Coorens, John Anderson, Grace Collord, Thomas Roberts, Emmy Dickens, Sam Behjati, Emily G. Mitchell

المصدر: Blood

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7d7fcc0d79d8a5b488eb99b3a57231Test
https://doi.org/10.1182/blood.2020010150Test

5

Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective

المؤلفون: Louise C. Strong, Christopher I. Amos, Elissa B. Dodd-Eaton, Jingxiao Chen, Wenyi Wang, Jing Ning, Jasmina Bojadzieva, Fan Gao, Xianhua Kong, Seung Jun Shin

المصدر: Cancer Res

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Time Factors, Datasets as Topic, Penetrance, Li-Fraumeni Syndrome, 0302 clinical medicine, Mutation Rate, Child, Neoplasms, Second Primary, Second primary cancer, Middle Aged, Pedigree, Child, Preschool, 030220 oncology & carcinogenesis, Cohort, Female, Adult, Heterozygote, medicine.medical_specialty, Adolescent, Genetic counseling, Genetic Counseling, Risk Assessment, Article, Young Adult, 03 medical and health sciences, Germline mutation, Predictive Value of Tests, Internal medicine, medicine, Humans, Genetic Predisposition to Disease, Germ-Line Mutation, Models, Genetic, business.industry, Infant, Newborn, Computational Biology, Infant, Cancer, medicine.disease, Confidence interval, 030104 developmental biology, Li–Fraumeni syndrome, Tumor Suppressor Protein p53, business, Software, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4879382bc2bbe4b8656d95cdd290b37Test
https://doi.org/10.1158/0008-5472.can-19-0725Test

6

Radiation therapy and secondary malignancy in Li‐Fraumeni syndrome: A hereditary cancer registry study

المؤلفون: Josh D. Schiffman, David K. Gaffney, Ying J. Hitchcock, Randa Tao, Yukun Luo, Wendy Kohlmann, Kristine E. Kokeny, Matthew M. Poppe, Peter G. Hendrickson, Luke Maese, Andrew J. Bishop, Shane Lloyd

المصدر: Cancer Medicine
Cancer Medicine, Vol 9, Iss 21, Pp 7954-7963 (2020)

مصطلحات موضوعية: p53, Male, 0301 basic medicine, Oncology, Cancer Research, Neoplasms, Radiation-Induced, Time Factors, medicine.medical_treatment, Germline, Li-Fraumeni Syndrome, 0302 clinical medicine, LFS, Risk Factors, Registries, Child, Li‐Fraumeni syndrome, Original Research, Neoplasms, Second Primary, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Treatment Outcome, Child, Preschool, 030220 oncology & carcinogenesis, Female, Hereditary Cancer, Adult, medicine.medical_specialty, Adolescent, Malignancy, lcsh:RC254-282, Risk Assessment, Young Adult, 03 medical and health sciences, Germline mutation, Internal medicine, RT‐induced malignancy, medicine, Humans, Genetic Predisposition to Disease, Radiology, Nuclear Medicine and imaging, Germ-Line Mutation, Retrospective Studies, Radiotherapy, business.industry, Infant, Newborn, Clinical Cancer Research, Infant, Secondary Malignancy, Histology, medicine.disease, United States, radiation, Radiation therapy, 030104 developmental biology, Li–Fraumeni syndrome, Neoplasm Recurrence, Local, Tumor Suppressor Protein p53, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9254236bdccd7615f9d953009eb2f409Test
https://doi.org/10.1002/cam4.3427Test

7

Rationale and design of ON-TRK:a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

المؤلفون: James C. H. Yang, Marcia S. Brose, Gilberto Castro, Edward S. Kim, Ulrik N. Lassen, Serge Leyvraz, Alberto Pappo, Fernando López-Ríos, John A. Reeves, Marc Fellous, Frédérique Penault-Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan Trent

المساهمون: National Taiwan University Cancer Center [Taipei], Abramson Cancer Center [philadelphia], University of Pennsylvania-Perelman School of Medicine, University of Pennsylvania, Instituto do Câncer do Estado = Cancer Institute of the State of São Paulo (ICESP), Levine Cancer Institute, Atrium Health [Charlotte, NC, USA] (LCIAH), Rigshospitalet [Copenhagen], Copenhagen University Hospital, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], St Jude Children's Research Hospital, Hospital Universitario HM Sanchinarro [Madrid, Spain], Bayer HealthCare Pharmaceuticals Inc [Whippany], Bayer HealthCare Pharmaceuticals, Inc. [Basel, Switzerland] (BHCP), Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, University of Washington [Seattle], Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Institut Gustave Roussy (IGR), Direction de la recherche [Gustave Roussy], Memorial Sloane Kettering Cancer Center [New York], Weill Medical College of Cornell University [New York], Sylvester Comprehensive Cancer Center [Miami, FL, USA] (S3C), Malbec, Odile, The Levine Cancer Institute, Direction de la recherche clinique [Gustave Roussy], Memorial Sloan Kettering Cancer Center (MSKCC)

المصدر: Yang, J C H, Brose, M S, Castro, G, Kim, E S, Lassen, U N, Leyvraz, S, Pappo, A, López-Ríos, F, Reeves, J A, Fellous, M, Penault-Llorca, F, Rudzinski, E R, Tabatabai, G, Vassal, G, Drilon, A & Trent, J 2022, ' Rationale and design of ON-TRK : a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib ', BMC Cancer, vol. 22, no. 1, 625 . https://doi.org/10.1186/s12885-022-09687-xTest
BMC Cancer
BMC Cancer, 2021, 22 (1), pp.625. ⟨10.1186/s12885-022-09687-x⟩
BMC Cancer, 2022, 22 (1), pp.625. ⟨10.1186/s12885-022-09687-x⟩